ArticleExperimental and therapeutic medicine2020

TRIM31 enhances chemoresistance in glioblastoma through activation of the PI3K/Akt signaling pathway.

Ming-De Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.